ConductScience.org, home

Paper39720899

Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study.

Wu X and 2 others. J Cell Mol Med, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study. Papers, record 39720899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39720899

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.58, provisional
iCite
Revised in PubMed
2026-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu XXiaodonghttps://orcid.org/0000-0002-1031-5319
2Song YYanhong
3Wu SShuodong

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Non-alcoholic Fatty Liver DiseaseMajor topic
Mendelian Randomization AnalysisMajor topic
InflammationMajor topic
Humans
Polymorphism, Single Nucleotide
Genetic Predisposition to Disease
Biomarkers

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137563310Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.Nat Immunol2023https://conductscience.org/library/papers/37563310PubMed
234275345Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach.Int J Immunopathol Pharmacol2021https://conductscience.org/library/papers/34275345PubMed
320454933Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis.Obes Surg2010https://conductscience.org/library/papers/20454933PubMed
423385644Lack of kinin B₁ receptor potentiates leptin action in the liver.J Mol Med (Berl)2013https://conductscience.org/library/papers/23385644PubMed
534698778Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.JAMA2021https://conductscience.org/library/papers/34698778PubMed
634447378Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression.Front Immunol2021https://conductscience.org/library/papers/34447378PubMed
726783377Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.Dis Markers2015https://conductscience.org/library/papers/26783377PubMed
829164242Mendelian Randomization.JAMA2017https://conductscience.org/library/papers/29164242PubMed
935447114Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice.J Biol Chem2022https://conductscience.org/library/papers/35447114PubMed
1027992443Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.PLoS One2016https://conductscience.org/library/papers/27992443PubMed
1129785076Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.World J Gastroenterol2018https://conductscience.org/library/papers/29785076PubMed
1235247611Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.Mol Metab2022https://conductscience.org/library/papers/35247611PubMed
1329967350Mechanisms of NAFLD development and therapeutic strategies.Nat Med2018https://conductscience.org/library/papers/29967350PubMed
1432413340Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/32413340PubMed
1524055326Observational research--opportunities and limitations.J Diabetes Complications2013https://conductscience.org/library/papers/24055326PubMed
1631292134Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.Diabetes2019https://conductscience.org/library/papers/31292134PubMed
1726050253Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.Int J Epidemiol2015https://conductscience.org/library/papers/26050253PubMed
1820858684Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.Diabetes2010https://conductscience.org/library/papers/20858684PubMed
1938015590Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele.Hepatol Commun2023https://conductscience.org/library/papers/38015590PubMed
2033200014Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history.World J Hepatol2020https://conductscience.org/library/papers/33200014PubMed

See all 28 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41795980[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/41795980PubMed
41617025HIF-2α induction in de novo lipogenesis in metabolic dysfunction-associated steatohepatitis is dependent on IL-21 signaling.J Biol Chem2026https://conductscience.org/library/papers/41617025PubMed
41036025Perturbation of Circulating Inflammatory Proteins Mediates the Relationship Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Multivariate and Mediation Mendelian Randomization Study.Health Sci Rep2025https://conductscience.org/library/papers/41036025PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL116356PubTator's text mininghttps://conductscience.org/library/genes/6356NCBI Gene
LIF3976PubTator's text mininghttps://conductscience.org/library/genes/3976NCBI Gene
TNFRSF11B4982PubTator's text mininghttps://conductscience.org/library/genes/4982NCBI Gene
TNFRSF93604PubTator's text mininghttps://conductscience.org/library/genes/3604NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39720899

GET https://conductscience.org/api/papers/v1/39720899/references?page=2